analyst ratings
12 articles
Albemarle Corporation's stock price reached a new one-year high on Tuesday, trading as high as $150.72 and closing at $145.4710 with a volume of 3,525,316 shares. The company has received recent analy...
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Receives Average Rating of “Moderate Buy” from Brokerages
Acumen Pharmaceuticals (NASDAQ:ABOS) has received an average rating of 'Moderate Buy' from the five financial analysts covering the company, as reported by MarketBeat. The analysis includes one sell a...
Shares of Alight Inc (NYSE: ALIT) dropped below the $1.80 mark to a new one-year low, trading at $1.75 after KeyCorp reduced its price target on ALIT from $6.00 to $2.50. Despite this downgrade, KeyCo...
Analysts from Wells Fargo & Company have recently raised their price target on Synchrony Financial (NYSE: SYF) to $100.00 from $95.00 and maintained an 'overweight' rating....
Truist Financial has raised its price target for Analog Devices (ADI) from $258.00 to $291.00, maintaining a hold rating on the stock. However, other research firms have also offered their analysis re...
TD Cowen raised its price target for American Noble Gas from $16.00 to $17.00, maintaining a hold rating on the stock. This update follows similar analyst evaluations of other equities within the tech...
Recent analyst reports indicate that both Piper Sandler and Raymond James Financial have set a new price target of $9.00 per share for Sight Sciences (NASDAQ: SGHT) on January 5, 2026....
According to MarketBeat reports, Janus International Group Inc. has received an average analyst rating of 'Hold'. Among the five analysts analyzing the company, one recommends a sell, three recommend ...
Seven financial analysts have given Bradmer Pharmaceuticals Inc., trading on the Toronto Stock Exchange under ticker GLX (TSE:GLX), an average rating of 'Strong Buy'. Among these, one analyst recommen...
Five financial analysts covering SURO Capital Corp., whose stock is listed on NASDAQ under the ticker SSSS, have collectively given a 'Buy' rating with an average price target of $10.83 for the next y...
Eleon Pharmaceuticals shares have been rated with a consensus 'Hold' by five research firms according to Marketbeat. Among these, one firm has given a sell rating, another a hold rating, and three gav...
Supernus Pharmaceuticals has received an average rating of 'Hold' with a consensus price target of $63.25 per share, based on ratings from seven analysts covering the company. The breakdown includes o...